Tilray: Fourth Quarter Consensus Estimates

Tilray (TSX: TLRY) (NASDAQ: TLRY) will be reporting its fourth quarter financial results on July 28 before the market opens. Analysts have a consensus $17.77 12-month price target on the company, via a total of 20 analysts, with 2 analysts having strong buy ratings. 3 analysts meanwhile have buy ratings, 14 have hold ratings and a single analyst has a sell rating on the company. The street high comes from Roth Capital with a $25 price target, and the lowest target sits at $1.27 from GLJ Research.

10 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 10 analysts is $146.19 million; this number has been revised upwards from $71.20 million at the start of the year. The highest revenue estimate is $175.4 million, while the lowest is $107.62 million.

Onto EBITDA estimates, there are currently 7 analysts who have fourth-quarter EBITDA estimates. The mean is currently $5.81 million, with this number being flat since the start of the year. The street high estimate currently sits at $11.7 million in EBITDA and the lowest is -$2.83 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q1 Earnings: A Bang Up Quarter

Copper’s Structural Shortage May Be Here to Stay | Colin Joudrie – Selkirk Copper

Why Barrick’s “Strong” Quarter Wasn’t So Strong | Q1 2026 Earnings

Recommended

Altamira Gold Extends Maria Bonita Footprint with 110 Metre Step-Out

Son of Mango Founder Arrested Over Billionaire Father’s Fatal Cliff Fall

Related News

Aurora: Canaccord Raises Price Target To $14.00 On Back Of Earnings

Last night, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported its second quarter 2020 earnings. They...

Friday, February 12, 2021, 04:02:00 PM

Tilray Selected To Supply Medical Cannabis For French Experimental Program

Tilray Inc (NASDAQ: TLRY) has expanded its international operations to now include France. The company...

Tuesday, January 26, 2021, 07:55:19 AM

Tilray Imports Medical Cannabis to USA to Assist Research on Breast Cancer Related Disorder

Tilray Inc (NASDAQ: TLRY) announced this morning that it has successfully imported medical cannabis from...

Thursday, October 24, 2019, 09:15:29 AM

Haywood Reiterates K92 Mining Price Target, Buy Rating

Las tweek, Haywood Capital Markets put out a quarterly preview and upcoming catalysts for K92...

Sunday, July 11, 2021, 03:08:00 PM

Roku: Analysts Expect Positive Net Income For Q2 2021

Roku Inc (NASDAQ: ROKU) will be reporting its second quarter financial results after the market...

Wednesday, August 4, 2021, 03:10:00 PM